Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rakez Kayed

Showing results (181-190 of 201) with videos related to

Pageof 21
Sort By:
Progress in Neurobiology|March 10, 2025
Pathogenic oligomeric Tau alters neuronal RNA processes through the formation of nuclear heteromeric amyloids with RNA-binding protein Musashi1Nicha Puangmalai, Abbigael E Aday, Madison Samples, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 24, 2017
Selective lowering of synapsins induced by oligomeric α-synuclein exacerbates memory deficitsMegan E Larson, Susan J Greimel, Fatou Amar, et al.
Vaccine|February 8, 2006
Immunization with fibrillar Abeta(1-42) in young and aged canines: Antibody generation and characteristics, and effects on CSF and brain AbetaElizabeth Head, Edward G Barrett, M Paul Murphy, et al.
Plos One|May 15, 2009
Amyloid formation by the pro-inflammatory S100A8/A9 proteins in the ageing prostateKiran Yanamandra, Oleg Alexeyev, Vladimir Zamotin, et al.
Aging and Disease|June 6, 2017
Cerebral Microvascular Accumulation of Tau Oligomers in Alzheimer's Disease and Related TauopathiesDiana L Castillo-Carranza, Ashley N Nilson, Candice E Van Skike, et al.
Nature Communications|November 2, 2021
Dynamic interactions and Ca<sup>2+</sup>-binding modulate the holdase-type chaperone activity of S100B preventing tau aggregation and seedingGuilherme G Moreira, François-Xavier Cantrelle, Andrea Quezada, et al.
Neurobiology of Disease|December 26, 2015
Caspase-cleaved tau exhibits rapid memory impairment associated with tau oligomers in a transgenic mouse modelYoungDoo Kim, Hyunwoo Choi, WonJae Lee, et al.
Acta Neuropathologica Communications|February 15, 2025
Retinal ganglion cell vulnerability to pathogenic tau in Alzheimer's diseaseMiyah R Davis, Edward Robinson, Yosef Koronyo, et al.
Biotechnology Progress|April 3, 2024
Development of a pan-tau multivalent nanobody that binds tau aggregation motifs and recognizes pathological tau aggregatesNikki McArthur, Bokyung Kang, Felix G Rivera Moctezuma, et al.
Parkinson'S Disease|June 8, 2026
Early Amyloid Formation and Neuroinflammatory Response in a Bigenic Mouse Model Expressing Human α-Synuclein and AβRadhika Thakore, Markus Aldén, Nadja Gustavsson, et al.
Pageof 21

Showing results (181-190 of 201) with videos related to

Sort By:
Pageof 21
Progress in Neurobiology|March 10, 2025
Pathogenic oligomeric Tau alters neuronal RNA processes through the formation of nuclear heteromeric amyloids with RNA-binding protein Musashi1Nicha Puangmalai, Abbigael E Aday, Madison Samples, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 24, 2017
Selective lowering of synapsins induced by oligomeric α-synuclein exacerbates memory deficitsMegan E Larson, Susan J Greimel, Fatou Amar, et al.
Vaccine|February 8, 2006
Immunization with fibrillar Abeta(1-42) in young and aged canines: Antibody generation and characteristics, and effects on CSF and brain AbetaElizabeth Head, Edward G Barrett, M Paul Murphy, et al.
Plos One|May 15, 2009
Amyloid formation by the pro-inflammatory S100A8/A9 proteins in the ageing prostateKiran Yanamandra, Oleg Alexeyev, Vladimir Zamotin, et al.
Aging and Disease|June 6, 2017
Cerebral Microvascular Accumulation of Tau Oligomers in Alzheimer's Disease and Related TauopathiesDiana L Castillo-Carranza, Ashley N Nilson, Candice E Van Skike, et al.
Nature Communications|November 2, 2021
Dynamic interactions and Ca<sup>2+</sup>-binding modulate the holdase-type chaperone activity of S100B preventing tau aggregation and seedingGuilherme G Moreira, François-Xavier Cantrelle, Andrea Quezada, et al.
Neurobiology of Disease|December 26, 2015
Caspase-cleaved tau exhibits rapid memory impairment associated with tau oligomers in a transgenic mouse modelYoungDoo Kim, Hyunwoo Choi, WonJae Lee, et al.
Acta Neuropathologica Communications|February 15, 2025
Retinal ganglion cell vulnerability to pathogenic tau in Alzheimer's diseaseMiyah R Davis, Edward Robinson, Yosef Koronyo, et al.
Biotechnology Progress|April 3, 2024
Development of a pan-tau multivalent nanobody that binds tau aggregation motifs and recognizes pathological tau aggregatesNikki McArthur, Bokyung Kang, Felix G Rivera Moctezuma, et al.
Parkinson'S Disease|June 8, 2026
Early Amyloid Formation and Neuroinflammatory Response in a Bigenic Mouse Model Expressing Human α-Synuclein and AβRadhika Thakore, Markus Aldén, Nadja Gustavsson, et al.
Pageof 21